Safety and Bactericidal Activity of Rifalazil in Patients with Pulmonary Tuberculosis
Rifalazil, also known as KRM-1648 or benzoxazinorifamycin, is a new semisynthetic rifamycin with a long half-life of approximately 60 h. Rifalazil has potent bactericidal activity against Mycobacterium tuberculosis in vitro and in animal models of tuberculosis (TB). Prior studies in healthy voluntee...
Bewaard in:
| Gepubliceerd in: | Antimicrob Agents Chemother |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Microbiology (ASM)
2001
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90587/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11408210/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.7.1972-1976.2001 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|